Dr. Kinneret Livnat Savitsky
Clinical Research
KAHR Medical Ltd
Israel
Biography
Dr. Savitsky was CEO of BiolineRx until October 2016. Dr. Savitsky has over 20 years of experience in early-stage drug development and in the past 12 years she held several management positions at BioLineRx, a clinical-stage, publicly-traded (NASDAQ: BLRX; TASE: BLRX) biopharmaceutical development company.
Research Interest
Clinical Research